Pneumococcal conjugate second or third-dose vaccines (PCVc) in Zimbabwe
Zimbabwe: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 91.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Zimbabwe, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Zimbabwe is 91.0%, measured in 2025.
The figure is up 4.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Zimbabwe peaked at 95.0% in 2013 and was at its lowest, 0.0%, in 2008.
That places Zimbabwe 61st out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Zimbabwe, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 21.0% | — |
| 2013 | 95.0% | +352.4% |
| 2014 | 91.0% | -4.2% |
| 2015 | 87.0% | -4.4% |
| 2016 | 90.0% | +3.4% |
| 2017 | 89.0% | -1.1% |
| 2018 | 89.0% | +0.0% |
| 2019 | 90.0% | +1.1% |
| 2020 | 86.0% | -4.4% |
| 2021 | 88.0% | +2.3% |
| 2022 | 90.0% | +2.3% |
| 2023 | 90.0% | +0.0% |
| 2024 | 91.0% | +1.1% |
| 2025 | 91.0% | +0.0% |
Zimbabwe compared with similar countries
- Zimbabwe's 91.0% is above the median for lower middle income countries, which is 84.0%, 1.1× the median. (47 countries reporting)
- Zimbabwe's 91.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.1× the median. (48 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Zimbabwe changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2013 | +352.4% | 21.0% | 95.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 65.2% | 0.0% | 95.0% | 10 |
| 2020s | 89.3% | 86.0% | 91.0% | 6 |
Countries ranked near Zimbabwe
More health data for Zimbabwe
- Un projection of annual infant deaths, annual growth rate -1.39 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.11 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 874.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,457 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 0.9632 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0689 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9673 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Zimbabwe?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Zimbabwe was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Zimbabwe?
- The highest recorded value was 95.0% in 2013.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Zimbabwe?
- The lowest recorded value was 0.0% in 2008.
- How does Zimbabwe rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Zimbabwe ranks 61st out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Zimbabwe?
- Over the last ten years it is up 4.6%. The long-run trend across the full record is volatile.
- Where does this Zimbabwe data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).